Ayesh, H.; Beran, A.; Suhail, S.; Ayesh, S.; Niswender, K.
Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials. Biomedicines 2024, 12, 2328.
https://doi.org/10.3390/biomedicines12102328
AMA Style
Ayesh H, Beran A, Suhail S, Ayesh S, Niswender K.
Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials. Biomedicines. 2024; 12(10):2328.
https://doi.org/10.3390/biomedicines12102328
Chicago/Turabian Style
Ayesh, Hazem, Azizullah Beran, Sajida Suhail, Suhail Ayesh, and Kevin Niswender.
2024. "Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials" Biomedicines 12, no. 10: 2328.
https://doi.org/10.3390/biomedicines12102328
APA Style
Ayesh, H., Beran, A., Suhail, S., Ayesh, S., & Niswender, K.
(2024). Comparative Analysis of Resmetirom vs. FGF21 Analogs vs. GLP-1 Agonists in MASLD and MASH: Network Meta-Analysis of Clinical Trials. Biomedicines, 12(10), 2328.
https://doi.org/10.3390/biomedicines12102328